DK3580197T3 - Oprensning af pleuromutilin - Google Patents
Oprensning af pleuromutilin Download PDFInfo
- Publication number
- DK3580197T3 DK3580197T3 DK18703600.9T DK18703600T DK3580197T3 DK 3580197 T3 DK3580197 T3 DK 3580197T3 DK 18703600 T DK18703600 T DK 18703600T DK 3580197 T3 DK3580197 T3 DK 3580197T3
- Authority
- DK
- Denmark
- Prior art keywords
- pleuromutilin
- purification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/36—Ortho- or ortho- and peri-condensed systems containing three rings containing eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/95—Spiro compounds containing "not free" spiro atoms
- C07C2603/98—Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members
- C07C2603/99—Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members containing eight-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17155542 | 2017-02-10 | ||
PCT/EP2018/053314 WO2018146264A1 (en) | 2017-02-10 | 2018-02-09 | Purification of pleuromutilin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3580197T3 true DK3580197T3 (da) | 2021-02-08 |
Family
ID=58017956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18703600.9T DK3580197T3 (da) | 2017-02-10 | 2018-02-09 | Oprensning af pleuromutilin |
Country Status (13)
Country | Link |
---|---|
US (1) | US10913703B2 (da) |
EP (1) | EP3580197B1 (da) |
JP (1) | JP7086974B2 (da) |
KR (1) | KR102509871B1 (da) |
CN (1) | CN110225903B (da) |
CA (1) | CA3051643A1 (da) |
DK (1) | DK3580197T3 (da) |
ES (1) | ES2858431T3 (da) |
IL (1) | IL268550B (da) |
MX (1) | MX2019008894A (da) |
PT (1) | PT3580197T (da) |
TW (1) | TWI762573B (da) |
WO (1) | WO2018146264A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113354538A (zh) * | 2020-03-03 | 2021-09-07 | 新疆上昵生物科技有限公司 | 一种高纯度截短侧耳素的提取方法 |
US20230218558A1 (en) * | 2020-04-17 | 2023-07-13 | Nabriva Therapeutics GmbH | Novel therapeutic use of pleuromutilins |
AR123965A1 (es) * | 2020-10-29 | 2023-01-25 | Elanco Tiergesundheit Ag | Proceso de purificación de pleuromutilinas |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4092424A (en) | 1964-04-17 | 1978-05-30 | Biochemie Ges.M.B.H. | Antibiotic derivatives |
GB1197942A (en) | 1967-08-15 | 1970-07-08 | Biochemie Gmbh | Process for the production of the Antibiotic Pleuromutilin |
US4129721A (en) | 1977-12-08 | 1978-12-12 | Eli Lilly And Company | A-40104 antibiotics and process for production thereof |
US4247542A (en) | 1978-06-22 | 1981-01-27 | Eli Lilly And Company | A-40104 Antibiotics and process for production thereof |
HUP9900973A3 (en) | 1996-01-03 | 2000-04-28 | Smithkline Beecham Plc | Carbamoyloxy derivatives of mutiline with antibacterial activity, pharmaceutical compns. contg. them and process for preparing the said compds. |
HUP0001741A3 (en) | 1996-08-02 | 2000-11-28 | Smithkline Beecham Plc | Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use |
UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
GB9918037D0 (en) | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
GB0017031D0 (en) | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
PE20020676A1 (es) | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
GB0207495D0 (en) | 2002-03-28 | 2002-05-08 | Biochemie Gmbh | Organic compounds |
GB0209262D0 (en) | 2002-04-23 | 2002-06-05 | Biochemie Gmbh | Organic compounds |
SI1534678T1 (sl) | 2002-07-24 | 2008-06-30 | Nabriva Therapeutics Ag | Plevromutilinski derivati kot antimikrobna sredstva |
GB0218578D0 (en) * | 2002-08-09 | 2002-09-18 | Glaxo Group Ltd | Novel method |
EP1663220B1 (en) | 2003-09-03 | 2009-12-02 | Glaxo Group Limited | Novel process for the preparation of pleuromutilin derivatives |
JP2008523016A (ja) | 2004-12-13 | 2008-07-03 | グラクソ グループ リミテッド | (5−アミノ−6−メトキシ−3−ピリジンカルボニル)カルバミン酸2−(s)−ヒドロキシムチリン14−エステルの新規の多形 |
GB0504314D0 (en) | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
JP2008534443A (ja) | 2005-03-10 | 2008-08-28 | スミスクライン・ビーチャム・コーポレイション | 新規な方法 |
EP2298733B1 (en) | 2005-06-27 | 2016-05-25 | Nabriva Therapeutics AG | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
GB0513058D0 (en) | 2005-06-27 | 2005-08-03 | Sandoz Ag | Organic compounds |
GB0515995D0 (en) | 2005-08-03 | 2005-09-07 | Sandoz Ag | Organic compounds |
TW200736203A (en) | 2005-11-18 | 2007-10-01 | Glaxo Group Ltd | New pleuromutilin derivative and its use |
PE20070825A1 (es) | 2005-11-18 | 2007-08-05 | Glaxo Group Ltd | Nuevo derivado de pleuromutilina y su uso |
EP1808431A1 (en) | 2006-01-16 | 2007-07-18 | Nabriva Therapeutics Forschungs GmbH | Mutilin derivatives and their use as pharmaceutical |
EP1908750A1 (en) | 2006-10-05 | 2008-04-09 | Nabriva Therapeutics Forschungs GmbH | Process for the preparation of pleuromutilins |
EP1972618A1 (en) | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
EP2014640A1 (en) | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Pleuromutilin derivatives |
EP2014645A1 (en) | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Pleuromutilin derivatives and their use as antimicrobials |
EP2159220A1 (en) | 2008-09-02 | 2010-03-03 | Nabriva Therapeutics AG | Organic compounds |
CN101838199B (zh) * | 2010-05-21 | 2013-01-30 | 西南大学 | 截短侧耳素的溶剂提取工艺 |
EP2390245A1 (en) | 2010-05-26 | 2011-11-30 | Nabriva Therapeutics AG | Enantiomerically pure amines |
EP2399904A1 (en) * | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Process for the preparation of pleuromutilins |
EP2433926A1 (en) | 2010-09-09 | 2012-03-28 | Nabriva Therapeutics AG | Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes |
CN102050737B (zh) * | 2010-12-10 | 2013-05-08 | 山东胜利股份有限公司 | 一种截短侧耳素的提取纯化方法 |
CN102351698A (zh) | 2011-08-15 | 2012-02-15 | 上海华震科技有限公司 | 一种用吸附色谱法从结晶母液中回收截短侧耳素的方法 |
EP3096751B1 (en) | 2014-01-22 | 2021-01-06 | Nabriva Therapeutics GmbH | 12-epi-pleuromutilins |
-
2018
- 2018-02-06 TW TW107104127A patent/TWI762573B/zh active
- 2018-02-09 MX MX2019008894A patent/MX2019008894A/es active IP Right Grant
- 2018-02-09 JP JP2019543084A patent/JP7086974B2/ja active Active
- 2018-02-09 CN CN201880008830.5A patent/CN110225903B/zh active Active
- 2018-02-09 US US16/482,809 patent/US10913703B2/en active Active
- 2018-02-09 DK DK18703600.9T patent/DK3580197T3/da active
- 2018-02-09 WO PCT/EP2018/053314 patent/WO2018146264A1/en active Search and Examination
- 2018-02-09 KR KR1020197022474A patent/KR102509871B1/ko active IP Right Grant
- 2018-02-09 PT PT187036009T patent/PT3580197T/pt unknown
- 2018-02-09 CA CA3051643A patent/CA3051643A1/en active Pending
- 2018-02-09 EP EP18703600.9A patent/EP3580197B1/en active Active
- 2018-02-09 ES ES18703600T patent/ES2858431T3/es active Active
-
2019
- 2019-08-06 IL IL268550A patent/IL268550B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL268550B (en) | 2021-05-31 |
KR20190117504A (ko) | 2019-10-16 |
US20200231529A1 (en) | 2020-07-23 |
ES2858431T3 (es) | 2021-09-30 |
TWI762573B (zh) | 2022-05-01 |
CN110225903A (zh) | 2019-09-10 |
US10913703B2 (en) | 2021-02-09 |
PT3580197T (pt) | 2021-03-02 |
JP7086974B2 (ja) | 2022-06-20 |
WO2018146264A1 (en) | 2018-08-16 |
KR102509871B1 (ko) | 2023-03-14 |
MX2019008894A (es) | 2019-10-09 |
CA3051643A1 (en) | 2018-08-16 |
TW201835024A (zh) | 2018-10-01 |
EP3580197B1 (en) | 2020-12-02 |
EP3580197A1 (en) | 2019-12-18 |
IL268550A (en) | 2019-09-26 |
JP2020507572A (ja) | 2020-03-12 |
CN110225903B (zh) | 2022-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3377059T3 (da) | Hæmmere af cxcr2 | |
DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
DK3180331T3 (da) | Polymorfer af selinexor | |
DK3506904T3 (da) | Behandling af demens | |
DK3390422T3 (da) | Krystalformer af lnt | |
DK3201323T3 (da) | Modificering af bakteriofag | |
DK3529236T3 (da) | Krystalformer af eravacyclin | |
DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
DK3544416T3 (da) | Applikation af væsker | |
DK3522921T3 (da) | Forebyggelse af allergi | |
DK3430004T3 (da) | Faststofformer af nilotinibsalte | |
DK3113773T3 (da) | Krystallinske former af grapiprant | |
DK3580197T3 (da) | Oprensning af pleuromutilin | |
DK3678644T3 (da) | Formuleringer af copanlisib | |
DK3582764T3 (da) | Behandling af alkoholisme | |
DK3781172T3 (da) | Behandling af lungebetændelse | |
UA36785S (uk) | Комплект етикеток | |
UA36777S (uk) | Комплект етикеток | |
UA36511S (uk) | Комплект етикеток | |
UA36757S (uk) | Комплект етикеток | |
UA36378S (uk) | Комплект етикеток | |
UA36364S (uk) | Комплект етикеток | |
UA36367S (uk) | Комплект етикеток |